Literature DB >> 9100279

Learning and retention in preclinical and early Alzheimer's disease.

E Grober1, C Kawas.   

Abstract

Accelerated forgetting has been proposed as the first sign in preclinical and early Alzheimer's disease (AD). The authors investigated learning and retention in participants who later developed AD with free and cued selective reminding (FCSR; H. Buschke, 1984; E. Grober & H. Buschke, 1987), a test that maximizes learning by inducing deep semantic processing and by controlling study and test conditions. AD patients in the preclinical stage recalled significantly fewer words than did matched control participants, indicating an impairment of learning; nonetheless, patients' retention was identical to that of control participants. A retention deficit was documented 3 years later for AD patients but not for control participants, whose retention was still perfect. Thus, a retention deficit is not present in preclinical AD when hallmark learning deficits can be documented. Detection of preclinical and very early AD may be best accomplished by using robust learning tests that control cognitive processing.

Entities:  

Mesh:

Year:  1997        PMID: 9100279     DOI: 10.1037//0882-7974.12.1.183

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  54 in total

Review 1.  Imaging Alzheimer's disease.

Authors:  Scott A Small
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

2.  Level of recall, retrieval speed, and variability on the Cued-Recall Retrieval Speed Task (CRRST) in individuals with amnestic mild cognitive impairment.

Authors:  Wendy S Ramratan; Laura A Rabin; Cuiling Wang; Molly E Zimmerman; Mindy J Katz; Richard B Lipton; Herman Buschke
Journal:  J Int Neuropsychol Soc       Date:  2012-01-23       Impact factor: 2.892

3.  Modeling and Estimating Recall Processing Capacity: Sensitivity and Diagnostic Utility in Application to Mild Cognitive Impairment.

Authors:  Michael K Wenger; Selamawit Negash; Ronald C Petersen; Lyndsay Petersen
Journal:  J Math Psychol       Date:  2010-02-01       Impact factor: 2.223

Review 4.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

5.  Sleep onset/maintenance difficulties and cognitive function in nondemented older adults: the role of cognitive reserve.

Authors:  Molly E Zimmerman; Marcelo E Bigal; Mindy J Katz; Adam M Brickman; Richard B Lipton
Journal:  J Int Neuropsychol Soc       Date:  2012-02-09       Impact factor: 2.892

6.  Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response.

Authors:  S Duke Han; Wes S Houston; Amy J Jak; Lisa T Eyler; Bonnie J Nagel; Adam S Fleisher; Gregory G Brown; Jody Corey-Bloom; David P Salmon; Leon J Thal; Mark W Bondi
Journal:  Neurobiol Aging       Date:  2006-01-24       Impact factor: 4.673

7.  Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.

Authors:  Eileen E Moran; Cuiling Wang; Mindy Katz; Laurie Ozelius; Alison Schwartz; Jelena Pavlovic; Roberto A Ortega; Richard B Lipton; Molly E Zimmerman; Rachel Saunders-Pullman
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

8.  Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery.

Authors:  Jane B Tornatore; Emory Hill; Jo Anne Laboff; Mary E McGann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

9.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

Review 10.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.